可注射的Ca/ε-氨基甲酸/德克斯酸水凝,用于有效控制急性出血
Uladzislau E Aharodnikau1, Yulia I Pristromova1, Pavel M Bychkovsky1
1Research Institute for Physical Chemical Problems of the Belarusian State University, Minsk, Belarus; Educational-Scientific-Production Republican Unitary Enterprise "UNITEHPROM BSU", Minsk, Belarus.
International journal of biological macromolecules
|April 25, 2025
概括
含有,e-氨基酸和酸的新复合水凝有效控制出血. 这些先进的血液静止剂通过减少血液流失和凝固时间,对手术和创伤应用具有显著的前景.
科学领域:
- 生物材料科学 生物材料科学
- 血液静止研究 血液静止研究
- 聚合物化学 聚合物化学
背景情况:
- 控制出血在手术和创伤护理中至关重要.
- 新型血液静止剂的开发对于改善患者的治疗结果至关重要.
- 现有代理商可能有局限性,需要新的解决方案.
研究的目的:
- 开发和描述/ε-氨基甲酸/德克斯酸复合水凝.
- 评估这些新型水凝的物理化学特性和静血潜力.
- 评估它们在控制出血中的有效性,无论是体外还是体内.
主要方法:
- 合成和描述复合水凝通过德克斯酸化.
- 评价水凝的特性:风湿学,胀,形态学,和 ε-氨基甲酸吸附.
- 在体外评估e-aminocaproic acid的释放,血液凝固时间,凝固指数和血液溶解.
- 使用大鼠肝脏出血模型进行体内评估,以测量出血时间和血液损失.
主要成果:
- 水凝表现出 ε-氨基甲酸的受控释放,最大吸附能力为80%.
- 试验室研究显示,血液凝固时间缩短,凝固指数增强,血液溶解最小.
- 在体内测试表明,在老鼠肝脏模型中,出血时间和平均血液损失显著减少.
- 复合水凝在血液静止效率方面表现优于对照实验.
结论:
- 开发的Ca/ε-aminocaproic acid/dextran酸基凝显示出显著的静血潜力.
- 这些水凝有效控制出血,为医疗应用提供了有希望的替代方案.
- 进一步的研究和开发可能会导致它们作为先进的静血剂在临床上使用.
相关概念视频
01:05Introduction to Hemostasis
4.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
545
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
545
01:30Epistaxis
111
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
111
01:20Extrinsic and Intrinsic Pathways of Hemostasis
3.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
3.6K
01:16Vascular Spasm
1.0K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.0K